US 11524987
Highly purified recombinant human insulin (RHI) API and methods of producing the same
granted A61KA61K38/28A61K9/0019
Quick answer
US patent 11524987 (Highly purified recombinant human insulin (RHI) API and methods of producing the same) held by Amphastar Pharmaceuticals, Inc. expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amphastar Pharmaceuticals, Inc.
- Grant date
- Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K38/28, A61K9/0019, A61K9/08, A61P